Latest posts tagged with #CheckPointInhibitors on Bluesky
This review highlights #OncolyticViruses as emerging #tumor therapeutics and summarizes advances in combining OVs with #immunotherapy—from #CheckpointInhibitors to cellular therapies—showing promise for improved outcomes.
#OpenAccess: doi.org/10.1016/j.ge...
Thank you to Dr. Hussein Tawbi @mdanderson.bsky.social
for presenting our #GrandRounds, sharing the latest advancements in immune #checkpointinhibitors for #melanoma that has metastasized to the brain.
Watch his full talk: youtube.com/watch?v=cGWS...
Adding anti-angiogenesis therapy to PD-1/PD-L1 + chemo improves PFS and ORR in ES-SCLC, especially in patients under 65. No OS benefit overall. Safety comparable.
🔗 buff.ly/tMshYDZ
#LungCancer #CheckpointInhibitors #MetaAnalysis
PD-1/PD-L1 inhibitors show promise in HBV-related hepatocellular carcinoma. Patients with low HBV DNA and early qHBsAg response had longer survival. Viral biomarkers could shape future immunotherapy strategies. buff.ly/ciwROOE
#LiverCancer #HBV #CheckpointInhibitors
📎 feeds.issuerdirect.com/news-release...
💡Research-use pembrolizumab from MedChemExpress: medchemexpress.com/Lambrolizuma...
#ESMO2025 #ESMO25 #mRNA #Inhibitors #CancerTherapy #ImmunoOncology #CheckpointInhibitors
Turning All Cancers Into Curable Diseases - Dr. Karen Knudsen MBA PhD - CEO, Parker Institute for Cancer Immunotherapy, joins me on Progress, Potential, And Possibilities #ProstateCancer #CARTCellTherapy #CheckpointInhibitors #TumorAntigens #TumorMicroenvironment www.youtube.com/watch?v=cyrO...
Advances in Vaccines, Checkpoint Blockade, and Chimeric Antigen Receptor−Based Cancer Immunotherapeutics
www.dl.begellhouse.com/journals/2ff...
#CancerImmunotherapy #CheckpointInhibitors #CARTTherapy
💡 Take-home message: Restoring antitumor immunity via multimodal, biomarker-guided strategies is the next frontier in post-ICI NSCLC.
#LungCancer #NSCLC #ImmunoOncology #CheckpointInhibitors #Medicalwatch
www.nature.com/articles/s41...
Immunotherapy for Cancer Success Rate: What Patients Need to Know in 2025
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IO #Immunotherapy #SuccessRate #CART #CheckpointInhibitors #ICIs
#Scancell #NationalCancerInstitute #UKbiotech #DNAplasmidvaccine #melanoma #SCOPEtrial #SCIB1 #iSCIB1+ #checkpointinhibitortherapy #advancedmelanoma #immunotherapy #melanomaantigens #TRP2protein #Tcells #checkpointinhibitors #metastaticmelanomatreatment
pharmaphorum.com/news/scancel...
In this week's post Jesse Kreger (@adamlmaclean.bsky.social) discusses his latest work in #cancer #systems #immunology together with Edgar Gonzalez to study the mechanisms of response of breast cancer to #checkPointInhibitors
Nivolumab + relatlimab show promising intracranial activity in melanoma brain metastases! A beacon of hope for resistant cases and a call for more research!
#Melanoma #BrainMetastases #Immunotherapy #Nivolumab #Relatlimab #CheckpointInhibitors #TCSC #Oncology
www.cancernetwork.com/view/nivolum...
A New Hope in the Fight Against Cancer 🧬✨
www.babykidshealth.com/immune-treat...
#cancertreatment #immunotherapy #healthnews #hopeforcancer #checkpointinhibitors #immunehealth #cancerresearch #dostarlimab #cancerhope #cancersurvivor #healthrevolution #fightcancer #sciencewins #health #healthnews
🎥 New on #OncologyBytes from #IUCS2024
Dr. Anupama Vijay shares a real-world UK audit of 1L mRCC treatment.
📊 Only 64% of patients received 2L therapy after progression.
📺 Watch: youtu.be/Qix6-H83_nw
🌐 Learn more at: oncoassist.com
#mRCC #RenalCancer #CheckpointInhibitors #Oncoassist #UKOncology
🎥 New on #OncologyBytes from #IUCS2024
Dr. Yüksel Ürün validates the MEET-URO prognostic score in real-world mRCC patients treated with Ipi/Nivo, Cabo/Ipi/Nivo & Pembro/Axi.
📺 Watch: youtu.be/k2BA8sVHD-Y
🌐 Learn more at: oncoassist.com
#mRCC #RenalCancer #PrognosticScore #CheckpointInhibitors
TIL is a form of #immunotherapy but is different from #checkpointinhibitors or #CARTcell therapy. Dr. Lee leads the TIL Therapy Program at Fred Hutch, which is the only cancer center in Washington, Idaho, Montana and Alaska that offers FDA-approved TIL therapy for melanoma. 3/10
💡 Takeaway: Different ICI combinations drive distinct CD8+ T cell dynamics, shaping immune responses for better outcomes! 💪🦠
#Immunotherapy #CancerResearch #CheckpointInhibitors #TCellBiology #Oncology #HeadAndNeckCancer
www.cell.com/cancer-cell/...
SCI members Nam Bui, Kristen Ganjoo & colleagues found that several #sarcoma types showed the highest RR and longest PFS. Their work offers insights into 54 sarcoma histologic and immunologic factors linked to response to immune #CheckPointInhibitors. pubmed.ncbi.nlm.nih.gov/39699310/
#KidneyCancerAwarenessWeek 🌍 🗞️
Dr. Ignacio Duran, Hospital Universitario Marques de Valdecilla, shares insights from key #kidneycancer studies presented at the ESMO 2024 Congress💡🎥
👉 https://buff.ly/42gQE9Y
#ESMO2024 #KidneyCancerResearch #OncologyUpdates #CheckpointInhibitors
#Pembrolizumab -induced #thyroiditis, hypophysitis and adrenalitis: a case of triple endocrine dysfunction. doi.org/10.1210/jcem...
Featured in #JCEMCaseReports #OpenAccess
#adrenal #pituitary #CheckpointInhibitors
@endocrinesociety.bsky.social
#CureCancer #AdvancedTherapies #Biopharma #PrecisionMedicine #CheckpointInhibitors #TCellTherapy #SolidTumorTherapy #HematologicCancers #StemCellResearch #CancerTreatment #TumorTargeting #TranslationalResearch #BiotechRevolution #ImmunoOncology #FutureOfMedicine #BreakthroughScience
#CureCancer #AdvancedTherapies #Biopharma #PrecisionMedicine #CheckpointInhibitors #TCellTherapy #SolidTumorTherapy #HematologicCancers #StemCellResearch #CancerTreatment #TumorTargeting #TranslationalResearch #BiotechRevolution #ImmunoOncology #FutureOfMedicine #BreakthroughScience
📝 Conclusion
It is crucial to ensure ICIs’ benefits in cancer care aren’t offset by renal complications. Timely diagnosis, avoiding ATIN-associated drugs, and leveraging patient-specific data on biomarkers is key
#Nephrology #Immunotherapy #CheckpointInhibitors
